Tomorrow the Danish Coloplast will report its past quarters results. For this year Coloplast's revenue will be around 17,95 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 16,45 billion Danish Krone.
The analysts expect for 2018 a net profit of 4,25 billion Danish Krone. The majority of the analysts expects for this year a profit per share of 20,04 Danish Krone. Based on this the price/earnings-ratio is 35,84.
Per share the analysts anticipate on a dividend of 17,04 Danish Krone per share. Thus the dividend yield equals 2,37 percent. The average dividend yield of the pharmaceutical companies is a low 0,5 percent.
Based on the current number of shares Coloplast's market capitalization equals 139,47 billion Danish Krone. The Coloplast stock was the past 12 months quite unstable. Since last May the stock is even 40 percent higher. This year the stock price moved between 522 and 745 DKK. Since 2008 the stock price is almost 793 percent higher.At 10.22 the stock trades 0,42 percent lower at 718,2 Danish Krone.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.